Skip to main content
. 2017 Mar 5;130(5):522–529. doi: 10.4103/0366-6999.200542

Figure 3.

Figure 3

The landscape of the identified mutations in seven anti-human epidermal growth factor receptor 2-targeted therapy-resistant genes. The number shown in the box meant the mean allele frequency of the identified mutations in that gene. R: Resistant group. EGFR: Epidermal growth factor receptor; GNAS: Guanine nucleotide-binding protein alpha stimulating; HRAS: HRas proto-oncogene; MLH1: mutL homolog 1; CDH1: Cadherin 1; NRAS: Neuroblastoma RAS viral oncogene homolog.